GDF15 and acute coronary syndrome: Previous reports have linked GDF15 with the risk of major bleeding in various clinical scenarios, including patients with end-stage kidney disease, patients on hemodialysis [29], individuals with AF receiving anticoagulation therapy [30], and those with acute coronary syndrome undergoing antiplatelet treatment [31].